What birth control methods are acceptable for breastfeeding mothers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Birth Control Methods for Breastfeeding Mothers

Breastfeeding mothers can safely use multiple contraceptive methods, with progestin-only options being preferred during the first 6 months postpartum, while combined hormonal contraceptives (containing estrogen) should be avoided until at least 3 weeks after delivery and ideally delayed until after 6 weeks due to concerns about milk production and thromboembolism risk. 1

Timing-Based Approach to Contraception During Breastfeeding

Lactational Amenorrhea Method (LAM)

  • Can be used immediately postpartum if all three criteria are met: (1) amenorrhea, (2) fully or nearly fully breastfeeding, and (3) less than 6 months postpartum 1
  • Provides approximately 98% contraceptive efficacy when criteria are strictly followed 1
  • Critical limitation: Does not protect against STIs/HIV; condoms should be added if any STI/HIV risk exists 1

Progestin-Only Methods (Preferred During Breastfeeding)

These methods do not adversely affect milk production or infant health and can be initiated early postpartum:

  • Progestin-only pills (POPs): Can be started at any time postpartum in non-breastfeeding women; for breastfeeding women, ideally started at 6 weeks to minimize infant hormone exposure, though can be used earlier if needed 2, 3
  • DMPA (Depo-Provera injection): Category 2 (advantages generally outweigh risks) for breastfeeding women less than 1 month postpartum 1
  • Implants: Category 2 for breastfeeding women less than 1 month postpartum 1
  • Levonorgestrel IUD (LNG-IUD): Category 2 for breastfeeding women less than 1 month postpartum 1
  • Progestin-only vaginal rings: Deliver hormones insufficiently active by oral route, minimizing infant exposure through breast milk; can be used continuously for 3-12 months with high efficacy (>98.5%) 4

Key advantage: Progestin-only methods may actually prolong lactational amenorrhea to 10-12 months, providing additional health benefits 4

Combined Hormonal Contraceptives (Estrogen + Progestin)

Strict timing restrictions apply due to dual concerns:

For Breastfeeding Women:

  • Category 4 (unacceptable health risk) before 3 weeks postpartum due to increased venous thromboembolism risk 1
  • Category 3 (risks usually outweigh benefits) from 3 weeks to 6 months postpartum due to potential negative effects on milk production 1
  • Combined oral contraceptives (COCs), transdermal patches, and vaginal rings (like NuvaRing) all fall under these restrictions 1, 5
  • Estrogen can reduce milk production, which may lead to earlier weaning or need for supplementation 2, 3

For Non-Breastfeeding Women:

  • Category 4 before 21 days postpartum due to thromboembolism risk 1, 6
  • Category 3 from 21-42 days if additional VTE risk factors present 1, 6
  • No restrictions after 42 days postpartum for otherwise healthy women 6

Barrier and Non-Hormonal Methods

These methods are always acceptable during breastfeeding:

  • Condoms: Do not affect breastfeeding; provide STI/HIV protection 1
  • Copper IUD (Cu-IUD): Can be inserted as early as 10 minutes after placental delivery, though expertise required due to soft uterine wall 1, 3
  • Withdrawal (coitus interruptus): Does not affect breastfeeding if used correctly, though has higher typical-use failure rates 1
  • Diaphragm/cervical cap: Should NOT be used as backup with vaginal ring methods due to interference with proper placement 5

Sterilization

  • Tubal sterilization and vasectomy are safe options with no restrictions related to breastfeeding status 1
  • No medical conditions absolutely restrict eligibility except known allergies to materials used 1

Clinical Decision Algorithm

Week 0-3 postpartum (breastfeeding):

  • LAM alone (if criteria met)
  • Progestin-only methods (POPs, DMPA, implants, LNG-IUD)
  • Barrier methods
  • Copper IUD
  • Avoid all combined hormonal contraceptives

Week 3-6 postpartum (breastfeeding):

  • Continue above options
  • Combined hormonal contraceptives may be considered but generally not recommended (Category 3)

After 6 weeks postpartum (breastfeeding):

  • All methods become more acceptable
  • Combined hormonal contraceptives still carry concerns about milk supply reduction but may be appropriate for women planning gradual weaning 2

Important Caveats

  • Drug interactions: Multiple medications can reduce contraceptive effectiveness, including anticonvulsants, rifampin, St. John's wort, and certain HIV/HCV medications; use additional barrier methods for 28 days after stopping these medications 5
  • Small amounts of contraceptive steroids pass into breast milk with all hormonal methods, though no harmful effects have been observed in breastfed infants 5, 4
  • Women with conditions making pregnancy high-risk should not rely on LAM alone due to higher typical-use failure rates 1
  • Immediate postpartum initiation of progestin-only methods is safe and may be preferable for women with limited healthcare access 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hormonal contraception and lactation.

Journal of human lactation : official journal of International Lactation Consultant Association, 1996

Research

Contraception during lactation.

Annals of medicine, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.